Kunal Gawri
YOU?
Author Swipe
View article: Physical and Psychological Impact of the Covid-19 Pandemic on Healthcare Workers, Including End of Life Care Providers
Physical and Psychological Impact of the Covid-19 Pandemic on Healthcare Workers, Including End of Life Care Providers Open
Background The COVID-19 pandemic has not only caused unprecedented distress in the community but has also resulted in significant physical and psychological exhaustion among healthcare workers (HCWs). This exhaustion could potentially lead…
View article: Therapeutic strategies for BRAF mutation in non-small cell lung cancer: a review
Therapeutic strategies for BRAF mutation in non-small cell lung cancer: a review Open
Lung cancer is the leading cause of cancer related deaths. Among the two broad types of lung cancer, non-small cell lung cancer accounts for 85% of the cases. The study of the genetic alteration has facilitated the development of targeted …
View article: Efficacy and outcomes of ramucirumab and docetaxel in patients with metastatic non-small cell lung cancer after disease progression on immune checkpoint inhibitor therapy: Results of a monocentric, retrospective analysis
Efficacy and outcomes of ramucirumab and docetaxel in patients with metastatic non-small cell lung cancer after disease progression on immune checkpoint inhibitor therapy: Results of a monocentric, retrospective analysis Open
Current first-line standard therapy for metastatic non-small cell lung cancer without driver mutations involves chemotherapy and immunotherapy combination. Prior to the advent of immune checkpoint inhibition, REVEL, a randomized phase III …
View article: OA13.02 Socioeconomic Disparities in Access to Treatment and Survival in Operable Malignant Pleural Mesothelioma in the United States
OA13.02 Socioeconomic Disparities in Access to Treatment and Survival in Operable Malignant Pleural Mesothelioma in the United States Open
View article: P01.09 Improved Outcomes With Ramucirumab & Docetaxel in Metastatic Non-Small Cell Lung Cancer After Failure of Immunotherapy
P01.09 Improved Outcomes With Ramucirumab & Docetaxel in Metastatic Non-Small Cell Lung Cancer After Failure of Immunotherapy Open
View article: Umbilical Cord Mesenchymal Stem Cells for COVID-19 ARDS: A Double Blind, Phase 1/2a, Randomized Controlled Trial
Umbilical Cord Mesenchymal Stem Cells for COVID-19 ARDS: A Double Blind, Phase 1/2a, Randomized Controlled Trial Open
PP.22.02 Open